Research Papers:

14-3-3σ attenuates RhoGDI2-induced cisplatin resistance through activation of Erk and p38 in gastric cancer cells

In-Kyu Kim, Sun-Mi Park, Hee Jun Cho, Kyoung Eun Baek, In-Koo Nam, Seung-Ho Park, Ki-Jun Ryu, Jinhyun Ryu, Jungil Choi, Soon-Chan Hong, Jae Won Kim, Chang Won Lee, Sang Soo Kang and Jiyun Yoo _

PDF  |  HTML  |  Supplementary Files  |  How to cite

Oncotarget. 2013; 4:2045-2056. https://doi.org/10.18632/oncotarget.1334

Metrics: PDF 2427 views  |   HTML 3670 views  |   ?  


In-Kyu Kim1,*, Sun-Mi Park1,*, Hee Jun Cho1,*, Kyoung Eun Baek1, In-Koo Nam1, Seung-Ho Park1, Ki-Jun Ryu1, Jinhyun Ryu2, Jungil Choi2, Soon-Chan Hong3, Jae Won Kim1, Chang Won Lee1, Sang Soo Kang2 and Jiyun Yoo1

1 Division of Applied Life Science/Research Institute of Life Science, Graduate School of Gyeongsang National University, Jinju, Korea.

2 Department of Anatomy and Neurobiology, Institute of Health Science, and Medical Research Center for Neural Dysfunction, School of Medicine, Gyeongsang National University, Jinju, Korea.

3 Department of Surgery, School of Medicine, Gyeongsang National University, Jinju, Korea.

* Contributed equally to this work.


Jiyun Yoo, email:

Sang Soo Kang, email:

Keywords: RhoGDI2, 14-3-3σ, gastric cancer, chemoresistance, metastasis

Received: August 27, 2013 Accepted: October 19, 2013 Published: October 19, 2013


Rho GDP dissociation inhibitor 2 (RhoGDI2) promotes tumor growth and malignant progression and enhances chemoresistance of gastric cancer. Recently, we noted an inverse correlation between RhoGDI2 and 14-3-3σ expression, which suggests that 14-3-3σ is a target of gastric cancer metastasis and the chemoresistance-promoting effect of RhoGDI2. Herein, we evaluated whether 14-3-3σ is regulated by RhoGDI2 and is functionally important for the RhoGDI2-induced cisplatin resistance of gastric cancer cells. We used highly metastatic and cisplatin-resistant RhoGDI2-overexpressing SNU-484 cells and observed decreased 14-3-3σ mRNA and protein expression. Depletion of 14-3-3σ in SNU-484 control cells enhanced cisplatin resistance, whereas restoration of 14-3-3σ in RhoGDI2-overexpressing SNU-484 cells impaired cisplatin resistance in vitro and in vivo. We also found that the phosphorylation levels of Erk and p38 kinases significantly decreased in RhoGDI2-overexpressing SNU-484 cells and recovered after 14-3-3σ expression, and that decreased activities of these kinases were critical for RhoGDI2-induced cisplatin resistance. In conclusion, 14-3-3σ is a RhoGDI2-regulated gene that appears to be important for suppressing the chemoresistance of gastric cancer cells.

Creative Commons License All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 1334